{"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.50","statisticalComment":"1- degree of freedom (1-df) likelihood ratio test (LRT) in a cell dose stratified Cox model","statisticalMethod":"Regression, Cox"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"13","upperLimit":"14","value":"13"},{"groupId":"OG001","lowerLimit":"13","upperLimit":"14","value":"14"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"dispersionType":"Inter-Quartile Range","groups":[{"description":"Subjects on the experimental arm will receive 90 minutes of hyperbaric oxygen therapy approximately six hours prior to hematopoietic stem cell infusion.\n\nHyperbaric Oxygen Therapy: The intervention consists of exposure to hyperbaric oxygen at 2.5 atmospheres absolute (ATA) for a total of 2 hours, in a single see-through hyperbaric chamber, breathing 100% oxygen for 90 minutes while subjects are resting in supine position. During the 2 hours, there will be compression and decompression phases for 15 minutes each in which subjects will be breathing compressed environmental air (21% oxygen).","id":"OG000","title":"Hyperbaric Oxygen Therapy"},{"description":"Subjects on the reference arm will not receive hyperbaric oxygen therapy prior to hematopoietic stem cell infusion.\n\nNo Hyperbaric Oxygen Therapy: The reference arm will not receive hyperbaric oxygen therapy prior to hematopoietic stem cell transplant.","id":"OG001","title":"No Hyperbaric Oxygen Therapy"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"100 days","title":"Length of Hospital Stay","type":"SECONDARY","unitOfMeasure":"Days"}